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A Deleterious EPHB4 Mutation Suppresses PROX1 Expression and
Disrupts Lymphatic Development in Neonatal Non-Immune Hydrops
Gangaram Akangire; Heather Menden; Sheng Xia; Atif Ahmed; Venkatesh Sampath
Children’s Mercy Kansas City

Background
• Hydrops Fetalis, a fatal condition, mostly
non-immune in origin (85%)
• Etiology in unknown in 20% cases
• 15% associated with lymphatic
malformation
• Ephrin type B receptor 4 (EPHB4) plays
important role in lymphatic development
• Prospero Homeobox 1 (PROX1), a
transcription factor, is responsible for
terminal lymphatic fate specification

Results

Results

• WES -EPHB4 c.2098G>A (p.Ala700Thr) variant
• MRI lymphangiogram-	
  Complete absence of any
visible central lymphatic ducts

Figure 1: (A) Postmortem image showing diffuse edema. (B and C): MRI lymphangiogram showing diffuse
ectasia of multiple subcutaneous lymphatic channels over the upper thighs, pelvis, and trunk the level of the
axilla. Absence of any visible central lymphatic ducts or structure suggests congenital absence or atresia of
the central collecting lymphatics.

• IHC studies- loss of PROX1 staining in the
endothelial cells of the large lymphatic channels
in the lung and small intestinal villi with
preservation of podoplanin expression in the
same channels.

Objective
• To test the hypothesis that EPHB4
mutations can cause hydrops fetalis and to
explore the role of PROX1

Design/Methods
• 35-week infant with non-immune hydrops
infant required thoracentesis due to pleural
effusions
• Infant died of septic shock on DOL 145
• Whole exome	
  sequencing (WES)
• MRI lymphangiogram
• Immunohistochemistry (IHC) on autopsy
specimens
• In-vitro functional studies-in human embryonic
kidney cells (HEK293) and immortalized
human pulmonary microvascular endothelial
cells (HPMEC-IM)

• Autopsy revealed anasarca, absent thoracic
duct, depletion of lymphoid tissue of the
reticuloendothelial system, lungs with pulmonary
lymphangiectasia

Figure 2: Histopathology showing immunohistochemistry of lung and intestinal tissue of our case with a 5month old matched control. Staining by podoplanin antibodies in control and case specimens of lung and
small intestine confirmed that lymphatic vascular development was normal. Absence of PROX1 staining
(a key lymphatic endothelial marker required for lymphatic valve development) in lung and small intestinal
specimens shows lack of lymphatic valve development in this case leading to non-immune hydrops.
Figure 3: EPHB4 mutant abolishes
signal when transfected into human
cells. (A) EPHB4 domain map with
the mutation shown at amino acid 700
in the kinase domain.
(B-D) Cell culture lysates were used
from human cell lines after overnight
wild-type (WT) and mutant (mut)
EPHB4 transfection and growth for 48
hours.
(B) HEK cell culture lysates were
used to obtain EPHB4
phosphorylation and EPHB4 by
immunoblot. N=3.
(C-D) Human lung endothelial
cell lysates were used to immunoblot
for the phosphorylation of EPHB4 and
ERK, as well as EPHB4, ERK, and
PROX1 (C), with densitometry shown
graphically (D). N=4. ***p<.001.

• In-vitro functional studies- EPHB4 (p.Ala700Thr)
variant disrupts phosphorylation of EPHB4 in
HEK293 and HPMEC-Im cells and results in
decreased ERK(extracellular signal related
kinase) phosphorylation (Thr980) and PROX-1
expression in HPMEC-Im

Conclusion
• Genetic mutation in the EPHB4 led to
hydrops in our proband by disrupting
PROX-1 mediated lymphatic development.

